Related by context. Frequent words. (Click for all words.) 65 randomized multicenter 65 double blinded randomized 64 Randomized controlled 64 Phase Ib II 64 BY ADRIAN NEMES 63 multicenter randomized double 62 ONTARGET 62 Randomised 62 placebo controlled Phase 62 dose escalation clinical 62 RE LY 62 placebo controlled clinical 62 By Arek Sarkissian 62 nonrandomized 62 phase Ib 62 blind multicenter 62 multicenter prospective 62 Phase Ib clinical 61 phase IIb clinical 61 placebo controlled randomized 61 prospective randomized controlled 61 CALGB 61 randomized Phase III 61 blinded placebo controlled 61 YOUR LOCAL ANIMAL SHELTER 61 Phase III randomized 61 multicenter randomized 61 prospective multicenter 61 multicenter Phase 61 phase IIa clinical 60 label multicenter 60 HOW LONG WAS 60 By HARVEY SIMPSON 60 phase IIa 60 active comparator 60 By PETER LARSEN 60 dose escalation trial 60 Phase IIIb 59 multicenter clinical 59 multicentre 59 TRITON TIMI 59 double blinded placebo 59 ongoing Phase 1b 59 teriflunomide 59 Initiates Phase II 59 SUCCEED trial 59 Phase 1b clinical 59 JAK inhibitor 59 PRECiSE 58 MKC# 58 HGS ETR2 58 sunitinib malate 58 Initiate Phase 58 TAXUS IV 58 randomized controlled clinical 58 By WILLIAM KELLY 58 MERLIN TIMI 58 Natural Catastrophe Stress 58 phase IIb 58 NATRECOR R 58 safety tolerability pharmacokinetics 58 EVEREST II 58 Sapacitabine 58 Prostate Lung Colorectal 57 NCCTG 57 Regulatory Disclosure 57 forodesine 57 Genz # 57 label dose escalation 57 prospectively defined 57 confirmatory Phase III 57 pharmacodynamic effects 57 pharmacokinetics PK 57 preclinical efficacy 57 CD#.# DOES NOT ENDORSE 57 SYMMETRY trial 57 Entereg R 57 SPIRIT IV 57 plus prednisone 57 CIMZIA TM 57 Visit http:/www.Comtex.com 56 Phase Ib 56 Commences Phase 56 By Neil Osterweil 56 ABSORB trial 56 Phase Ia 56 SPIRIT III 56 By BRENDAN KIRBY 56 GRNVAC1 56 Alzheimer Disease Cooperative 56 placebo controlled 56 Traficet EN 56 Phase 2b study 56 MIRCERA 56 secondary efficacy endpoints 56 Allovectin 7 ® 56 Phase IIB 56 unblinding 56 dose pharmacokinetic 56 pharmacokinetic parameters 56 Daclizumab